APYX

Insider Trades

Name	Value	Action	Price	Current Price
Hill Matthew CChief Financial Officer $6.8k6k shares BuyAug 13, 2024 $1.13 --
Hill Matthew CChief Financial Officer $6.0k5.3k shares BuyAug 13, 2024 $1.13 --

News

prnewswire.comBody by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runwayprnewswire.comMay 27

globenewswire.comNew Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®globenewswire.comMay 21

globenewswire.comApyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuctionglobenewswire.comMay 14

globenewswire.comApyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™globenewswire.comMay 11

seekingalpha.comApyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7

Trade APYX

About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.

CEO: Charles D. Goodwin
IPO Date: Jan 2, 2019

Market Data

Open: $4.20
High: $4.24
Low: $4.01
Volume: 194.8K
Avg Volume: 175.5K
52W High: $5.08
52W Low: $1.59

Valuation

Market Cap: $172M
Enterprise Value: $180M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-9.1M
Revenue: $53M
Net Income: $-11M
Cash: $32M
Debt: $39M

Events

EarningsAug 6

EPS est. -0.09